

Programming microalgae for molecular purity
We engineer proprietary microalgae strains in sterile closed-loop photobioreactors, synthesizing high-purity bioactive compounds with verified carbon-negative yield.
Thermodynamic and molecular verification
99.8%
Bioactive compound purity
-1.8kg
CO2 sequestered per kg synthesized
12+
Proprietary engineered strains






Closed-loop cellular engineering
By bypassing wild harvesting, we program specific metabolic pathways to deliver consistent, clinical-grade outputs.
Strain Programming
Sterile Synthesis
Carbon Capture
We optimize the photosynthetic efficiency of microalgae strains to synthesize targeted bioactive compounds.
Closed, sterile photobioreactors eliminate environmental contaminants and ensure absolute molecular consistency.
Our metabolic platform integrates directly with industrial emissions, utilizing point-source carbon as a primary feedstock.


Targeted molecular synthesis platforms
The metabolic diversity of marine microalgae represents an untapped library of clinical solutions. By programming specific strains in closed, sterile photobioreactors, we yield precise molecular profiles optimized for pharmaceutical and industrial applications.
Our platform operates on a closed-loop synthesis model, integrating directly with industrial emissions. This thermodynamic reality ensures that every gram of high-purity bioactive compound synthesized acts as a permanent carbon sink.
Accelerate your transition
Partner with Valgogenix to secure high-purity bioactive compounds with a verified carbon-negative footprint. We support active research licensing and institutional investment opportunities.

Valgogenix Biotech
Engineering tomorrow through biotechnology, molecular research and sustainable scientific innovation. We develop advanced biotechnology solutions that enable cleaner industries, healthier communities and a more sustainable future.
Platform
Overview
About
Science
Pipeline
Sustainability
Careers
Inquiries
info@valgogenix.in
Bengaluru, Karnataka
2026 Valgogenix Biotech-Clinical-grade synthesis platforms.
MOLECULAR PURITY - CARBON-NEGATIVE YIELD
